GlassScriptPhysician profile
Leticia Ramirez
NPI 1649669185
$2,400.21
in general payments reported to CMS, 2019-2025
21 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $331 · 2023: $1,083 · 2024: $366 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $480.94 | 2022-2025 | Impella |
| Atricure, INC. | $321.65 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.53 | 2022-2025 | Lifevest |
| Abbvie INC. | $171.76 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $165.78 | 2022-2023 | Giapreza |
| Abbott Laboratories | $160.35 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Melinta Therapeutics, LLC | $124.99 | 2023 | Kimyrsa |
| Paratek Pharmaceuticals, INC. | $124.45 | 2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $115.80 | 2021-2024 | Camzyos |
| Shionogi INC | $94.40 | 2022 | |
| Edwards Lifesciences Corporation | $76.59 | 2022-2023 | Mitris Resilia Mitral Valve |
| Chiesi USA, INC. | $54.85 | 2022 | |
| Medtronic, INC. | $45.69 | 2024 | Penditure |
| Potrero Medical, INC. | $43.80 | 2021 | |
| Kestra Medical Technology Services, INC. | $43.78 | 2024-2025 | Assure Wcd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $31.83 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.41 | 2021-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $20.32 | 2025 | Arexvy |
| Novartis Pharmaceuticals Corporation | $19.72 | 2023 | |
| Csl Behring | $18.80 | 2023 | Kcentra |
| Mimedx Group, INC. | $15.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leticia Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.